Director at UnitedHealth (UNH) granted 320 deferred stock units

Q: What insider transaction did UNH director John H. Noseworthy report?

John H. Noseworthy reported receiving a grant of 320 deferred stock units of UnitedHealth Group common stock. The units were granted as regular quarterly compensation for his service as a director on the company’s Board.

Q: What are deferred stock units in the context of UNH director compensation?

For UnitedHealth Group directors, deferred stock units are equity awards granted as regular quarterly compensation. They are immediately vested when granted but must be retained by the director until completion of service on the company’s Board of Directors.

Q: Why must the UNH director retain the deferred stock units until leaving the Board?

The filing states that deferred stock units must be retained until the director’s completion of service on the Board . This requirement aligns director compensation with longer-term Board service and keeps the equity award tied to ongoing governance responsibilities.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.

Director John H. Noseworthy received a grant of 320 deferred stock units of UnitedHealth Group common stock as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board. Following this award, he directly holds 7,369 shares of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Noseworthy John H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	320	$0.00	--

Holdings After Transaction: Common Stock — 7,369 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Deferred stock units granted: 320 units Shares held after transaction: 7,369 shares Grant price per share: $0.0000 per share +2 more

5 metrics

Deferred stock units granted 320 units Regular quarterly compensation for director service

Shares held after transaction 7,369 shares Direct holdings of common stock following the award

Grant price per share $0.0000 per share Reported transaction price for the deferred stock unit grant

Acquire transactions in this filing 1 transaction Form 4 transactionSummary acquireCount

Buy and sell transactions in this filing 0 buys, 0 sells Form 4 transactionSummary buyCount and sellCount

Key Terms

deferred stock units, regular quarterly compensation, immediately vested, completion of service on the Board

4 terms

deferred stock units financial

"Represents deferred stock units that are granted as regular quarterly compensation"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

regular quarterly compensation financial

"granted as regular quarterly compensation for service as a director"

immediately vested financial

"Deferred stock units are immediately vested, but must be retained"

completion of service on the Board financial

"must be retained by the director until the director's completion of service on the Board"

Form 4 Insider Transactions: What Each Field Means →

04/06/2026 - 05:04 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Noseworthy John H

(Last)

(First)

(Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE

MINNESOTA

55344

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/01/2026		A		320⁽¹⁾	A	$0	7,369	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for John H. Noseworthy M.D.	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did UNH director John H. Noseworthy report?

John H. Noseworthy reported receiving a grant of 320 deferred stock units of UnitedHealth Group common stock. The units were granted as regular quarterly compensation for his service as a director on the company’s Board.

How many UnitedHealth Group (UNH) shares does John H. Noseworthy hold after this Form 4?

After the reported grant, John H. Noseworthy directly holds 7,369 shares of UnitedHealth Group common stock. This figure reflects his position immediately following the award of 320 deferred stock units as director compensation.

What are deferred stock units in the context of UNH director compensation?

For UnitedHealth Group directors, deferred stock units are equity awards granted as regular quarterly compensation. They are immediately vested when granted but must be retained by the director until completion of service on the company’s Board of Directors.

Are the deferred stock units granted to the UNH director immediately vested?

Yes, the deferred stock units granted to the UnitedHealth Group director are immediately vested. However, despite vesting at once, they must be held and cannot be disposed of until the director finishes serving on the Board.

Why must the UNH director retain the deferred stock units until leaving the Board?

The filing states that deferred stock units must be retained until the director’s completion of service on the Board. This requirement aligns director compensation with longer-term Board service and keeps the equity award tied to ongoing governance responsibilities.